Privately-financed solutions in the health-care sector: Bilfinger Berger and Siemens receive order for cancer therapy centre in Kiel

March 19, 2008

March 19, 2008

Privately-financed solutions in the health-care sector:
Bilfinger Berger and Siemens receive order for cancer therapy centre in Kiel

Bilfinger Berger, already established as a partner in the privately financed health-care sector of the United Kingdom and Australia, is expanding its concessions business to the health-care sector in Germany. A project company in which Bilfinger Berger and Siemens each have an equal share has been selected by the state of Schleswig-Holstein to design, finance, build and, over a period of 25 years, to operate an innovative new particle therapy center in Kiel. The order, with a total investment volume of about €250 million, is the largest public private partnership project in the German health-care sector to date. Bilfinger Berger’s equity commitment amounts to €10 million.

Bilfinger Berger is contributing its extensive experience in financing, construction and building operations, Siemens will assume responsibility for the technical operation of the particle therapy system and other medical technology. The project company receives contractually-fixed payments in return for ensuring the therapy center’s availability.

Particle therapy is a forward-looking treatment for cancer patients. It involves exposing the tumor to charged particle beam energy which can be targeted more precisely than other methods and thus causes significantly fewer side effects. Beginning in 2012, about 3,000 patients a year will be treated in Kiel. Patients will come from all over Northern Germany and Southern Scandinavia. In addition to particle therapy, the new center will have facilities for conventional cancer treatment and an in-patient ward.